AI- 6938
.
Special/Executive Session Board of Supervisors Mtg-CANCELED
- Meeting Date:
- 02/28/2023
- Title:
- Discussion and direction regarding the Opioid Multi District Litigation
- Submitted By:
- Tim Mattix, Board of Supervisors
- Department:
- Board of Supervisors
Presentation:
No A/V Presentation
Recommendation:
Document Signatures:
# of ORIGINALS
Submitted for Signature:
Submitted for Signature:
NAME
of PRESENTER:
of PRESENTER:
Christine J. Roberts
TITLE
of PRESENTER:
of PRESENTER:
Chief Civil Deputy County Attorney
Mandated Function?:
Source of Mandate
or Basis for Support?:
or Basis for Support?:
Information
Agenda Item Text:
Discussion and direction regarding the National Opioids Settlement Agreements with Teva, Allergan, CVS, Walgreens, and Walmart.
Pursuant to A.R.S. § 38-431.03(A)(3) and (4), the Board may go into executive session for legal advice with the attorney of the public body and to consider its position and instruct its attorneys regarding the public body's position in pending litigation.
Pursuant to A.R.S. § 38-431.03(A)(3) and (4), the Board may go into executive session for legal advice with the attorney of the public body and to consider its position and instruct its attorneys regarding the public body's position in pending litigation.
Background:
In anticipation of a global settlement in the Opioid MDL, on July 9, 2020, at a Special Meeting, the Board of Supervisors approved the County Attorney’s recommendation to participate in the One Arizona Memorandum of Understanding (MOU), outlining the settlement allocation and structure, and authorized the County Attorney to sign the MOU on behalf of the County.
On July 21, 2021, a $26 Billion global settlement was reached with the three largest Opioid distributors: McKesson, Cardinal Health and AmeriSource Bergen, and manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson and Johnson. This global settlement includes states, counties and cities. Cochise County signed on to the settlements and the funds are being distributed in accordance with the One Arizona Distribution of Settlement Funds Agreement.
In late 2022, agreements were announced with three pharmacy chains - CVS, Walgreens, and Walmart, and two additional manufacturers - Allergan and Teva. The next stage of the settlement process is for counties to sign on to the settlements. The funds from these settlements will be distributed in accordance with the One Arizona Distribution of Settlement Funds Agreement. At this time the Cochise County Attorney’s Office would like to discuss the settlements with the Board of Supervisors and solicit guidance and direction from the Board.
On July 21, 2021, a $26 Billion global settlement was reached with the three largest Opioid distributors: McKesson, Cardinal Health and AmeriSource Bergen, and manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson and Johnson. This global settlement includes states, counties and cities. Cochise County signed on to the settlements and the funds are being distributed in accordance with the One Arizona Distribution of Settlement Funds Agreement.
In late 2022, agreements were announced with three pharmacy chains - CVS, Walgreens, and Walmart, and two additional manufacturers - Allergan and Teva. The next stage of the settlement process is for counties to sign on to the settlements. The funds from these settlements will be distributed in accordance with the One Arizona Distribution of Settlement Funds Agreement. At this time the Cochise County Attorney’s Office would like to discuss the settlements with the Board of Supervisors and solicit guidance and direction from the Board.
Department's Next Steps (if approved):
Implement any direction provided by Board of Supervisors, including contacting the Arizona Attorney General’s Office to discuss acceptance/rejection of the settlement and submitting any signed documents.
Impact of NOT Approving/Alternatives:
Potential for lower settlement or an unfavorable allocation of the settlement to the County.
To BOS Staff: Document Disposition/Follow-Up:
N/A